Which of these 2 stocks can turn out to be absolute gem? – Arcos Dorados Holdings Inc. (ARCO), Alder Biopharmaceuticals, Inc. (ALDR)

The shares of Arcos Dorados Holdings Inc. have decreased by more than -30.92% this year alone. The shares recently went down by -3.38% or -$0.25 and now trades at $7.15. The shares of Alder Biopharmaceuticals, Inc. (NASDAQ:ALDR), has jumped by 27.07% year to date as of 05/17/2018. The shares currently trade at $14.55 and have been able to report a change of 0.87% over the past one week.

The stock of Arcos Dorados Holdings Inc. and Alder Biopharmaceuticals, Inc. were two of the most active stocks on Thuday. Investors seem to be very interested in what happens to the stocks of these two companies but do investors favor one over the other? We will analyze the growth, profitability, risk, valuation, and insider trends of both companies and see which one investors prefer.

Next 5Y EPS Growth: 11.90% versus 23.46%

When a company is able to grow consistently in terms of earnings at a high compound rate have the highest likelihood of creating value for its shareholders over time. Analysts have predicted that ARCO will grow it’s earning at a 11.90% annual rate in the next 5 years. This is in contrast to ALDR which will have a positive growth at a 23.46% annual rate. This means that the higher growth rate of ALDR implies a greater potential for capital appreciation over the years.

Profitability and Returns

Growth alone cannot be used to see if the company will be valuable. Shareholders will be the losers if a company invest in ventures that aren’t profitable enough to support upbeat growth. In order for us to accurately measure profitability and return, we will be using the EBITDA margin and Return on Investment (ROI), which balances the difference in capital structure. The ROI of ARCO is 19.50% while that of ALDR is -104.20%. These figures suggest that ARCO ventures generate a higher ROI than that of ALDR.

Cash Flow

The value of a stock is ultimately determined by the amount of cash flow that the investors have available. Over the last 12 months, ARCO’s free cash flow per share is a positive 1.27, while that of ALDR is negative -4.61.

Liquidity and Financial Risk

The ability of a company to meet up with its short-term obligations and be able to clear its longer-term debts is measured using Liquidity and leverage ratios. The current ratio for ARCO is 1.10 and that of ALDR is 13.30. This implies that it is easier for ARCO to cover its immediate obligations over the next 12 months than ALDR. The debt ratio of ARCO is 0.04 compared to 0.57 for ALDR. ALDR can be able to settle its long-term debts and thus is a lower financial risk than ARCO.


ARCO currently trades at a forward P/E of 12.93, a P/B of 3.25, and a P/S of 0.47 while ALDR trades at a P/B of 3.26, and a P/S of 621.19. This means that looking at the earnings, book values and sales basis, ARCO is the cheaper one. It is very obvious that earnings are the most important factors to investors, thus analysts are most likely to place their bet on the P/E.

Analyst Price Targets and Opinions

The mistake some people make is that they think a cheap stock has more value to it. In order to know the value of a stock, there is need to compare its current price to its likely trading price in the future. The price of ARCO is currently at a -41.63% to its one-year price target of 12.25. Looking at its rival pricing, ALDR is at a -42.85% relative to its price target of 25.46.

When looking at the investment recommendation on say a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell), ARCO is given a 1.50 while 2.10 placed for ALDR. This means that analysts are more bullish on the outlook for ALDR stocks.

Insider Activity and Investor Sentiment

Short interest or otherwise called the percentage of a stock’s tradable shares currently being shorted is another data that investors use to get a handle on sentiment. The short ratio for ARCO is 0.16 while that of ALDR is just 9.33. This means that analysts are more bullish on the forecast for ARCO stock.


The stock of Alder Biopharmaceuticals, Inc. defeats that of Arcos Dorados Holdings Inc. when the two are compared, with ALDR taking 4 out of the total factors that were been considered. ALDR happens to be more profitable, generates a higher ROI, has higher cash flow per share, higher liquidity and has a lower financial risk. When looking at the stock valuation, ALDR is the cheaper one on an earnings, book value and sales basis. Finally, the sentiment signal for ALDR is better on when it is viewed on short interest.

Previous ArticleNext Article

Related Post

Should You Buy Ampio Pharmaceuticals, Inc. (AMPE) ... Ampio Pharmaceuticals, Inc. (NYSE:AMPE) shares are up more than 101.07% this year and recently decreased -4.74% or -$0.09 to settle at $1.81. Marinus ...
Zynga Inc. (ZNGA) Internals Are Exhibiting Conflic... Zynga Inc. (NASDAQ:ZNGA) gained 1.34% in Friday’s session, going up from its prior closing price of $3.73 to $3.78 The stock price went upward in 5 of...
Choosing Between F.N.B. Corporation (FNB) and Firs... F.N.B. Corporation (NYSE:FNB) and First Horizon National Corporation (NYSE:FHN) are the two most active stocks in the Regional - Southeast Banks indus...
Dissecting the Numbers for Tenet Healthcare Corp. ... Tenet Healthcare Corp. (NYSE:THC) shares are down more than -7.88% this year and recently decreased -1.01% or -$0.14 to settle at $13.67. Community He...
Huntsman Corporation (HUN) vs. Praxair, Inc. (PX):... Huntsman Corporation (NYSE:HUN) shares are up more than 3.18% this year and recently decreased -0.72% or -$0.25 to settle at $34.35. Praxair, Inc. (NY...